Our data lends mechanistic support to these studies, suggesting that Myc engages OXPHOS machinery as one of the earliest metabolic alterations to exacerbate oxidative metabolism in lymphoma cells, simultaneous with that of nucleotide biosynthesis and transcription. The gene discussed is MYC; the disease is lymphoma.